CareDx to Participate in Upcoming Conferences

SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the 2021 Wells Fargo Healthcare Conference and H.C. Wainwright 23^rd Annual Global Investment Conference.

CareDx’s management will be participating in the 2021 Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 3:20 p.m Eastern Time. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

CareDx’s management will be participating in the H.C. Wainwright 23^rd Annual Global Investment Conference with a presentation available on Monday, September 13, 2021 at 7:00 a.m Eastern Time. To listen to the webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com

Investor Relations
Ian Cooney
(415) 287-2300 x3550
investor@caredx.com